You are here

WP9

In line with the deposited models, a series of 7 face-to-face courses will be created on diabetes (beginner), oncology (beginner and advanced), other diseases (beginner and advanced),  as well as models on safety related endpoints, thereby disseminating the principles of model-based drug development through the newly-developed interoperability framework. In addition, the course material and web-based self-education will be created and made available to the modelling community. To evaluate the implementation of the various deliverables from the other work packages and to achieve a critical mass in adoption of the newly developed tools, an internship mechanism for PhD students and postdoctoral fellows will be arranged.

Main outcomes of WP9

  • Seven face-to-face courses on diabetes, oncology, other diseases, and safety related models
  • Web-based self-education material on diabetes, oncology, other diseases and safety related models
  • Mechanism for internships for PhD students and postdoctoral fellows

 

  • Timeline posted on 4 months 3 weeks ago

    Drug Combinations in Oncology, Rocchetti Tumor Growth Inhibition model Predictive PK-PD modelling of tumor growth after administration of antiangiogenic and cytotoxic drugs, as single-agents and in... Read more

  • Timeline posted on 4 months 3 weeks ago

    Online course material on antibiotics and bacterial infections adapted from the Infectious disease course in model-informed drug development. The material includes a brief background to the type of... Read more

  • Timeline posted on 4 months 3 weeks ago

    Model-informed drug discovery and development online course to illustrate the principles of cardiac safety in drug discovery and development. This includes consideration on  preclinical,... Read more

  • Timeline posted on 4 months 3 weeks ago

    An agonist-antagonist interaction model for prolactin release following risperidone and paliperidone treatment. Model used (Friberg et al. CPT, 2009) Material extracted from the DDMoRe face-to-face... Read more

  • Timeline posted on 4 months 3 weeks ago

    Tumor Growth Inhibition models An estimation-simulation study with the Simeoni model Predictive PK-PD modelling of tumor growth after administration of a cytotoxic drugs as single-agent. Model used... Read more

  • Timeline posted on 1 year 3 months ago

    The DDMoRe consortium concludes the series of comprehensive face-to-face courses with the first advanced course introducing the principles of model-informed drug development, covering a range of... Read more

  • Feb 08 to Feb 12
    , 2016
    Sweden
    Events posted on 1 year 8 months ago

    This DDMoRe course in Infectious Diseases is one in a series of comprehensive face-to-face courses introducing the principles of model-informed drug development, covering a range of therapeutic areas... Read more

  • News posted on 1 year 8 months ago

    Public DDMoRe course: Model-Informed Drug Development in Infectious Diseases   Join us for this public DDMoRe course on 8–12 February 2016 at The Biomedical Centre, Uppsala, Sweden  Read more and... Read more

  • Timeline posted on 1 year 8 months ago

    This DDMoRe course in Infectious Diseases is one in a series of comprehensive face-to-face courses introducing the principles of model-informed drug development, covering a range of therapeutic areas... Read more

  • Jan 18 to Jan 22
    , 2016
    Sweden
    Events posted on 1 year 9 months ago

    This Pharma lead DDMoRe course in Cardiac Safety evaluation is one in a series of comprehensive face-to-face courses introducing the principles of model-informed drug discovery and development,... Read more

Pages